Found 76 matching trials
Study of LN-145/LN-145-S1 Autologous Tumor Infiltrating Lymphocytes in the Treatment of Squamous Cell Carcinoma of the Head & Neck PHASE2 Multicenter, multicohort, non-randomized, prospective, open label, interven...
Show More Location
University of Alabama
Learn More & Join Trial
To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma PHASE1 The primary objective of this Phase 1 clinical trial is to evaluate the fea...
Show More Location
Department of Oncology
Learn More & Join Trial
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma PHASE2 Background:
\- The National Cancer Institute (NCI) Surgery Branch has deve...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) In Combo With Durvalumab in Non-Small Cell Lung Cancer PHASE2 This study is a Phase 2, open-label, multicenter study evaluating adoptive ...
Show More Location
University of California San Diego, Moores Cancer Center
Learn More & Join Trial
Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts NA Purpose of this Pilot Study: The investigators want to study the safety, si...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
A Study Using Tumor-Reactive Autologous Tumor Infiltrating Lymphocytes (TIL) in Metastatic Melanomas PHASE2 The purpose of this protocol is to determine whether autologous TIL infused...
Show More Location
John Wayne Cancer Institute
Learn More & Join Trial
Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma PHASE2 The purpose of this study is to find out more about the effects of an inves...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
Adoptive Cell Therapy With (LN-145) in Combination With Pembrolizumab in Treating Patients With Unresectable or Metastatic Transitional Cell Cancer Who Have Failed Cisplatin-Based Chemotherapy PHASE2 This phase II trial studies how well autologous tumor infiltrating lymphocy...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
ACT-TIL and ANV419 for Advanced Melanoma. PHASE1 In this study we aim to investigate safety and tolerability of tumor-infilt...
Show More Status
Active Not Recruiting
Location
University Hospital Basel
Learn More & Join Trial
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab PHASE2 Background:
Cell therapy is an experimental cancer therapy. It takes young...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial